• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of progression in hypertensive renal disease in children.儿童高血压肾病进展的预测因素
J Clin Hypertens (Greenwich). 2004 Apr;6(4):186-91. doi: 10.1111/j.1524-6175.2004.02617.x.
2
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.高血压患者的亚临床肾损伤:打开一扇观察心血管系统的肾脏之窗。聚焦微量白蛋白尿。
Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85.
3
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.
4
Risk factors for renal failure in children with non-glomerular nephropathies.
Pediatr Nephrol. 2004 Feb;19(2):178-86. doi: 10.1007/s00467-003-1329-4. Epub 2003 Dec 18.
5
Proteinuria: its clinical importance and role in progressive renal disease.
Am J Kidney Dis. 2000 Apr;35(4 Suppl 1):S97-105. doi: 10.1016/s0272-6386(00)70237-x.
6
Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat.高血压 Fawn-Hooded 大鼠的肾脏血管功能障碍先于肾脏损伤的发展。
Am J Physiol Renal Physiol. 2010 Mar;298(3):F625-33. doi: 10.1152/ajprenal.00289.2009. Epub 2009 Dec 9.
7
Nocturnal and Circadian Rhythm of Blood Pressure Is Associated with Renal Structure Damage and Function in Patients with IgAN.IgA肾病患者血压的昼夜节律和昼夜节律与肾脏结构损伤及功能相关。
Arch Med Res. 2016 Jan;47(1):25-32. doi: 10.1016/j.arcmed.2016.01.001. Epub 2016 Jan 20.
8
The role of systemic hypertension in the progression of nondiabetic renal disease.
Kidney Int Suppl. 2000 Apr;75:S44-8.
9
Blood Pressure, Proteinuria, and Renal Function Decline: Associations in a Large Community-Based Population.血压、蛋白尿与肾功能下降:基于大型社区人群的关联
Am J Hypertens. 2015 Sep;28(9):1150-6. doi: 10.1093/ajh/hpv003. Epub 2015 Feb 11.
10
[Progression factors in chronic kidney disease. Non-immunological mechanisms].[慢性肾脏病的进展因素。非免疫机制]
Nefrologia. 2009;29 Suppl 1:16-24. doi: 10.3265/NEFROLOGIA.2009.29.S.1.5633.EN.FULL.

引用本文的文献

1
Burden of Hypertension and Abnormal Glomerular Permeability in Hypertensive School Children.高血压学龄儿童的高血压负担及肾小球通透性异常
Nephrourol Mon. 2016 May 21;8(4):e37568. doi: 10.5812/numonthly.37568. eCollection 2016 Jul.

本文引用的文献

1
Clinical and research aspects of ambulatory blood pressure monitoring in children.儿童动态血压监测的临床与研究方面
J Pediatr. 2004 Jan;144(1):7-16. doi: 10.1016/j.jpeds.2003.09.050.
2
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.慢性肾脏病的进展:血压控制、蛋白尿及血管紧张素转换酶抑制的作用:一项患者水平的荟萃分析
Ann Intern Med. 2003 Aug 19;139(4):244-52. doi: 10.7326/0003-4819-139-4-200308190-00006.
3
Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.氯沙坦对儿童蛋白尿的长期抗蛋白尿及肾脏保护疗效与安全性
J Pediatr. 2003 Jul;143(1):89-97. doi: 10.1016/S0022-3476(03)00279-8.
4
Where are all the blood-pressure genes?所有的血压基因都在哪里?
Lancet. 2003 Jun 21;361(9375):2149-51. doi: 10.1016/S0140-6736(03)13694-X.
5
Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.延缓慢性肾病的进展:残余蛋白尿这一被忽视的问题。
Kidney Int. 2003 Jun;63(6):2254-61. doi: 10.1046/j.1523-1755.2003.00033.x.
6
Ambulatory blood pressure monitoring in pediatric renal transplantation.
Pediatr Transplant. 2003 Apr;7(2):86-92. doi: 10.1034/j.1399-3046.2003.00059.x.
7
Reflux nephropathy and hypertension: correlation with the progression of renal damage.反流性肾病与高血压:与肾损害进展的相关性
Pediatr Nephrol. 2003 Mar;18(3):241-5. doi: 10.1007/s00467-003-1068-6. Epub 2003 Feb 26.
8
Left ventricular mass and systolic performance in pediatric patients with chronic renal failure.慢性肾功能衰竭儿科患者的左心室质量和收缩功能
Circulation. 2003 Feb 18;107(6):864-8. doi: 10.1161/01.cir.0000049744.23613.69.
9
Day- and night-time blood pressure elevation in children with higher grades of renal scarring.肾瘢痕程度较高的儿童白天和夜间血压升高。
J Pediatr. 2003 Feb;142(2):117-22. doi: 10.1067/mpd.2003.13.
10
Office and ambulatory blood pressure elevation in children with chronic renal failure.慢性肾衰竭患儿的诊室血压和动态血压升高
Pediatr Nephrol. 2003 Feb;18(2):145-9. doi: 10.1007/s00467-002-1030-z. Epub 2002 Dec 18.

儿童高血压肾病进展的预测因素

Predictors of progression in hypertensive renal disease in children.

作者信息

Lurbe Empar, Alvarez Vicente, Redon Josep

机构信息

Pediatric Nephrology Unit, Hospital General, University of Valencia, Avenida Tres Cruces s/n, 46014 Valencia, Spain.

出版信息

J Clin Hypertens (Greenwich). 2004 Apr;6(4):186-91. doi: 10.1111/j.1524-6175.2004.02617.x.

DOI:10.1111/j.1524-6175.2004.02617.x
PMID:15073472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8109707/
Abstract

In hypertensive renal disease in children, several risk factors influence the development and the rate of progression of renal damage, including blood pressure levels, proteinuria, lipid disorders, and genetic differences. The impact of blood pressure on renal structures, the most important of the factors, depends not only on blood pressure levels, but also on the persistence of the blood pressure levels over time, mainly during the hours when the patient is resting or sleeping. Abnormal circadian variability is frequently observed in patients with renal damage, and nocturnal blood pressure reduction should be a major therapeutic objective to protect against a decline in renal function. Proteinuria is a guide for establishing targets and for monitoring treatment. It should be reduced as much as possible to obtain maximal renoprotective effect. The role of the other factors, such as lipid disorders and genetics, remains elusive.

摘要

在儿童高血压肾病中,有几个危险因素会影响肾损害的发生和进展速度,包括血压水平、蛋白尿、脂质紊乱和基因差异。血压对肾脏结构的影响是这些因素中最重要的,它不仅取决于血压水平,还取决于血压水平随时间的持续性,主要是在患者休息或睡眠的时间段。肾损害患者经常观察到昼夜节律异常,夜间血压降低应成为预防肾功能下降的主要治疗目标。蛋白尿是设定治疗目标和监测治疗的指标。应尽可能降低蛋白尿,以获得最大的肾脏保护作用。其他因素,如脂质紊乱和遗传学的作用仍不明确。